By:
On:
In: General Health, Healthy Living, Infectious Disease, Public Health, Vitamins / Drugs

THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The BidenContinue Reading

By:
On:
In: Alternative Medicine, Infectious Disease, Multiple Sclerosis, Public Health, Vitamins / Drugs

THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading

By:
On:
In: General Health, Health Insurance, Mental Health, Public Health

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — Getting prior authorizations to see a specialist, dealing with errors on medical bills and even scheduling appointments can be a big hassle. That’s clear to anyone who has spent time on the phone handling issues with insurance companies or doctors’ offices. For someContinue Reading

By:
On:
In: Healthy Living, Infectious Disease, Public Health, Vitamins / Drugs

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — It’s hard to resist those big, pleading eyes in the pet store window. But buyer beware. Pet store puppies may infect people with a bacteria for which no common antibiotic treatment exists, a new study warns. Campylobacter jejuni (C jejuni) cannot be treatedContinue Reading

By:
On:
In: Care Giving, Doctors and Health Care, Health & Technology, Mental Health, Public Health, Seniors

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — Older adults who are socially isolated are more likely to experience serious disability or die after a stay in the intensive care unit (ICU), new research reveals. “This important research finding sheds light on a crucial health care issue that has become moreContinue Reading

By:
On:
In: General Health, Health Insurance, Public Health, Seniors

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — When Americans are eligible for Medicare at age 65, they see a significant drop in their out-of-pocket medical costs. Lowering the eligibility age would save even more, especially for people with the highest out-of-pocket costs, according to a new study. “Medicare really improvesContinue Reading

By:
On:
In: Health & Technology, Kids' Health, Public Health, Vitamins / Drugs

TUESDAY, Sept. 14, 2021 (HealthDay News) — An experimental Ebola vaccine appeared effective in children and adults in a clinical trial. Two doses of Johnson & Johnson’s Ebola vaccine appear safe, well tolerated and produce a strong immune response in people over the age of 1, according to two just-publishedContinue Reading

By:
On:
In: Health & Technology, Infectious Disease, Public Health, Vitamins / Drugs

TUESDAY, Sept. 14, 2021 (HealthDay News) – New data out of Israel, to be published this week, could bolster the notion that a third booster shot of the COVID-19 vaccine significantly lowers a recipient’s odds for severe illness. The data is scheduled to be published in the peer-reviewed New EnglandContinue Reading

By:
On:
In: Alzheimers, Health Insurance, Mental Health, Public Health, Vitamins / Drugs

TUESDAY, Sept. 14, 2021 (HealthDay News) — U.S. approval of the Alzheimer’s drug Aduhelm is already mired in controversy. Now a new study finds that most Alzheimer’s patients could not have taken part in clinical trials that led to the green light. In June, the U.S. Food and Drug AdministrationContinue Reading